Select BioVenture Partners seeks $200m for bioscience fund

Florida-based Select BioVentures is seeking $200m for its current fund. The vehicle will target Florida-based bioscience companies with an emphasis on late pre-clinical and early clinical stage private or public biopharmaceutical, medical device and molecular diagnostic companies. The firm is comprised of strategic and operating consultancy The Sage Group and three former C-level professionals with …